Sequestration Saps 40% of Framingham Heart Study's Budget

Published: Sep 10, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The famed Framingham Heart Study, the longest-running cardiovascular disease clinical trial in the U.S., faces layoffs and closures as its annual budget drops from $9 million to $4 million amid federal sequestration. The famed Framingham Heart Study lost 40% of its budget to sequestration, which means layoffs and closures are on the way for the nation's longest-running cardiovascular disease trial. The study lost $4 million of its annual $9 million budget thanks to automatic funding cuts that took effect amid federal sequestration, reported.

Help employers find you! Check out all the jobs and post your resume.

Back to news